Sources | Names Used |
---|---|
GDSC1000 | MPS-1-IN-1 |
PharmacoGx | MPS-1-IN-1 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TARBP2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.01 |
mRNA | NKPD1 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.01 |
mRNA | L3HYPDH | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | EVI2B | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | KDELR3 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | RYR3 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.01 |
mRNA | DEPDC4 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
mRNA | CTNNAL1 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
mRNA | PPM1N | GDSC1000 | pan-cancer | AAC | 0.078 | 0.01 |
mRNA | DFNB59 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |